S1P2 Human Lysophospholipid (S1P) GPCR Cell Based Agonist & Antagonist Calcium Flux LeadHunter Assay - FR
OVERVIEW
DOCUMENTS/REFERENCES
Biological Information
No. of Assays on Panel:
2
Assays on Panel:
Family
GPCR
Name
S1P2 Human Lysophospholipid (S1P) GPCR Cell Based Agonist Calcium Flux LeadHunter Assay - FR
Item
2133
Protein
S1P2
Organism
Human
Assay Sub Type
Cell Based
Family
GPCR
Name
S1P2 Human Lysophospholipid (S1P) GPCR Cell Based Antagonist Calcium Flux LeadHunter Assay - FR
Item
2135
Protein
S1P2
Organism
Human
Assay Sub Type
Cell Based
Family:
GPCR
Sub Family:
Lysophospholipid (S1P)
Class:
Class A
Protein Name:
S1P2
Uniprot Number:
O95136
Protein Aliases:
EDG5|Endothelial differentiation G-protein coupled receptor 5|Sphingosine 1-phosphate receptor Edg-5|S1P receptor Edg-5
Gene Name:
S1PR2
Gene ID:
9294
Gene Aliases:
Gpcr13|H218|AGR16
Organism:
Human
Cell Type:
CHO-K1
Assay Information
Assay Type:
Functional
Assay Sub Type:
Cell Based
Functional Mode:
Agonist & Antagonist
Detection Method:
Fluorimetry
Measured Response:
Fluorescence
Testing Information
Incubation:
RT
Control Activator:
Sphingosine 1-phosphate (S1P) (30 nM)
Test Concentration / Dose:
Eurofins will provide IC/EC50 calculation if 5 or more concentrations are selected.
Test Sample Requirements:
Minimum for 1) Screen: 70 µL of 10 mM stock -OR- 1 mg (pre-weighed) for 10µM finµL testing. 2) Dose Response: 90 µL of 10 mM stock -OR- 1 mg (pre-weighed) for a top concentration at 10 µM.
Minimum Order Quantity:
16
Turnaround Time
Standard:
15 Business Days
Clinical Relevance
Therapeutic Area:
Inflammation/Allergy
Additional Information
Brand:
LeadHunter
Testing Location:
France - Celle L'Evescault
RELATED SOLUTIONS
S1P2 Human Lysophospholipid (S1P) GPCR Cell Based Agonist Calcium Flux LeadHunter Assay - FR
Item: 2133
S1P2 Human Lysophospholipid (S1P) GPCR Cell Based Antagonist Calcium Flux LeadHunter Assay - FR
Item: 2135
Questions? Contact Us
You can easily get in touch with a Eurofins Discovery Expert or get help from our Customer Service team. Reach out with questions, or to discuss your specific discovery challenges.
